Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma – ASCO

American Society of Clinical Oncology (ASCO) shared a post on their LinkedIn page:

“Latest from ASCO Plenary Series: Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma. Tune in tomorrow, February 6, at 3 PM ET for the live presentation, expert discussion, and Q&A.

View abstract.”

Source: American Society of Clinical Oncology (ASCO)/LinkedIn